Evidence map›Paper›PMID 35235855›Full record

ArticleJournal of pain and symptom management2022

Tailoring Pain Interference Measurement in People with Cancer: A Feasibility Study.

Salene M W Jones, Joseph M Unger

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Journal of pain and symptom management, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06922188 (Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06922188 recruitingnot on this mapstarted 2025, after this paper: background citation

Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia

TypeobservationalSponsorFred Hutchinson Cancer CenterRan2025 to 2029Enrolled2,460ConditionsFinancial Hardship, Alzheimer&#39, s Disease (AD), Alzheimer&#39
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. PROMIS.British dental journal · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Salene M W JonesDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. Electronic address: smjones3@fredhutch.org.
Joseph M UngerDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Fred Hutch Cancer Center · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Marian Esvelt · 1985 to 2026
$296.4M
SWOG NCORP Research BaseUG1CA189974 · NCI · THE HOPE FOUNDATION · PI CHARLES D. BLANKE, DAWN HERSHMAN · 2014 to 2026
$80.6M
NCI NIH HHS P30 CA015704NCI NIH HHS UG1 CA189974
6 · The paper itself

Abstract

contextMost patient-reported outcomes (PRO) are not directly tailored to an individual patient's values, partially because tailored PROs require clinical interviews or are difficult to use in statistical analyses.

objectivesThis study tested a method for tailoring pain PROs, Precision PROs, that can be implemented, and analyzed using standard statistical tests.

methodsPeople with cancer and pain (n = 231) completed an online survey and then a second survey (n = 161) one to two weeks later. Participants reviewed the PROMIS pain interference item bank, chose the four items most important to their quality of life, and then completed those items. Kappas compared choices between the two surveys. Participants completed measures of pain intensity, physical function, and a standard pain interference measure.

resultsAll participants were able to select four items that were personally meaningful. Only one item (enjoyment of life) was chosen by more than half the sample (50.6%). Kappas for item choice were in the moderate to nearly perfect range for 32 of 35 items. The majority of the sample (59%) preferred tailoring their own PRO questions to completing a previously determined, non-patient-specific PRO. The Precision PRO scores had similar associations with pain intensity and physical function as the standard pain interference measure.

conclusionThe Precision PRO approach was feasible, more preferred by patients, and showed consistency over a short timeframe. This approach could be used to make PRO assessment in clinical care and clinical trials more patient-centered. Additional research is needed to determine the generalizability of this approach to other outcomes and populations.

Indexed as

NeoplasmsQuality of LifeFeasibility StudiesHumansPainPain Measurementindividualized assessmentPatient-reported outcomespersonalized measures

Identifiers

PMID35235855
PMCPMC9189031
OpenAlexW4214707681

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.